Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dKuuCfbwoceBzSiBbciT

July 2, 2012
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNM SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNM prior to publication. Questions and comments may be directed to SmartBrief at snm@smartbrief.com.

  Top Story 
  • Noninvasive heart tests could help avoid invasive procedures
    Use of noninvasive imaging, including SPECT and PET, can help avoid the use of unnecessary invasive tests, such as coronary angiography, in patients with chest pain, according to initial results from the Evaluation of Integrated Cardiac Imaging study. "In general, about 70% of the time, the noninvasive test gave the same result as the angiography, so invasive procedures could be avoided," said researcher Dr. Jose Zamorano from the University Hospital Ramón y Cajal in Spain. According to researchers, about 25% of patients who had chest pain had heart disease, lower than the expected 60%. TheHeart.org (Montreal) (free registration) (6/29) LinkedInFacebookTwitterEmail this Story
 
  Clinical News & Research 
  • Experts assess the state of in-development radiation drugs
    The FDA launched its medical countermeasures program in 2010 to address growing concerns about radiation exposure, but success is still far off. None of the 30 licensed drugs and clinical-stage candidates for radiation syndromes is far advanced, according to the NIH. Federal agencies encourage repurposing currently used drugs for treatment of acute radiation syndrome. The NIH plans to broaden efforts to encourage more small and large drug companies to focus on radiation drugs. Chemical & Engineering News (6/25) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  • Nordion: Decision on Maple reactor case could come in September
    Nordion said arbitration panel members could deliver a decision in September regarding its dispute with Atomic Energy of Canada over the canceled Maple reactor project. Nordion served a notice of arbitration to the Canadian government in 2008 when the government decided to halt the reactor project amid design difficulties. The Maple reactors were intended to replace the National Research Universal reactor, a major producer of the medical isotope molybdenum-99. AuntMinnie.com (free registration) (6/29) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • Medtech firms may face additional costs in wake of ACA ruling
    A Kalorama Information report says the medtech industry could face additional financial burdens as a result of the Supreme Court's decision to uphold the Affordable Care Act, which includes the 2.3% medical device tax set to begin next year. Johnson & Johnson said the tax could cost it as much as $250 million, while Teleflex could pay $15 million. Healthcare IT News (6/29) LinkedInFacebookTwitterEmail this Story
  Featured Content 
 

  Health Policy 
  Advancing Health Care 
  From SNM 
  • Journal of Nuclear medicine ranks as best imaging journal
    The Journal of Nuclear Medicine (JNM) — the flagship publication of the Society of Nuclear Medicine (SNM) — is once again ranked the top medical imaging journal worldwide, according to new data released in the 2011 Journal Citation Reports© published by Thomson Reuters. This is the fourth consecutive year in which JNM has taken the top honors. LinkedInFacebookTwitterEmail this Story
SNM  |  Molecular Imaging Community  |  SNM Annual Meeting  |  SNM Learning Center

News  |  SNM on Facebook  |  SNM Channel on YouTube  |  SNM's Virtual March for Health

  SmartQuote 
Don't feel entitled to anything you didn't sweat and struggle for."
--Marian Wright Edelman,
African-American activist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent SNM SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information